It’s been more than 2 years and the covid 19 virus still has the same presence and even getting more dangerous with the passage of time. As per many medical experts, different variants of coronavirus will take birth and disrupt the medical system and mankind. The newly detected variant of covid 19 is a new example that the infection is still very young and getting more lethal as it becomes old.
The Antiviral Pills Are A Game-Changer & Showed Positive Results
According to the CEO of Pfizer, the covid 19 virus ain’t going anywhere until 2024 and it will also depend upon how people adapt to the vaccines. If people will stay unvaccinated, they are themselves inviting the covid 19 virus to take away their lives.
The initial studies have found that the two doses of the vaccine are alone not sufficient enough to fight the latest version of covid and citizens require an extra layer of protection to secure their immunity system and increase its power to face the infection caused by the omicron subtype during the peak time.
Dr. Anthony Fauci, The Chief Medical Adviser to the US Federal Government has stated that booster shots are the ultimate tool to beat the virus and safeguard our lives at the time of the upcoming wave of the new version.
Some results have also shown the individuals with 3 doses are still not completely covered with the security. Although the severity level amongst those who received only initial doses is more when compared to those who also added booster shots to their vaccine numbers.
Since the start of the month of October, the US Food and Drug Administration has been closely monitoring a new entrant in the world of treatment for Covid 19 virus especially against the omicron version.
The antiviral pills have been in talking terms with the medical agencies and the initial results shared by the pharmaceutical companies like Merck and Pfizer have shown some promising results during the clinical trials.
The antiviral pills from Pfizer Paxlovid showed some great results and reduced the hospitalization rate and death rates amongst the severely infected covid 19 patients by 90 percent. On the other hand, Merck’s antiviral pill managed to control hospital admissions and death by only 50 percent which is also a great number.
President Joe Biden showed more confidence in Pfizer’s Antiviral pills and the US FDA gave authorization to the Paxlovid and the same day FDA also nodded yes to Merck’s treatment pills.
The pills are considered to be a game-changer and manage to protect the most vulnerable people by taking 4-5 pills twice a day for at least 5 days continuously.
The antiviral pills will help in reducing the serious symptom cases in the US but how to effectively make use of antiviral pills is surely a matter of concern.
As of now, there can be a shortage of antiviral pills and the companies might take up at least six months to fulfill the demand in the long term.
